Table 1 Clinical pathological characteristics of our patients' series

Median age

59.6 ± 10.58 years old

M/F

26/38

CRS without HIPEC

5

7.8

CRS + HIPEC

59

92.2

Primary tumor:

• Colon

22

34.4

• Gastric

21

32.8

• Ovary

9

14.1

• Other tumor with malignant ascites

3

4.7

• Other

4

6.2

Performance Karnovsky Status (PKS) > 90%

58

90.6

Median PCI

2

CC:

• 0

50

89.3

• 1

4

7.1

• 2

2

3.6

Neoadjuvant chemotherapy

15

25.4

Adjutant chemotherapy

55

93.2

Adjutant HIPEC

12

20.3

Palliative HIPEC

3

5.1

Intraoperative drugs:

• Cysp. + Myto

34

57.6

• Oxaliplatin

14

23.7

• Doxo

4

6.8

• Other

7

11.9